^
    Evidence Level:
    Sensitive: C3 – Early Trials

    [PGR overexpression-Breast Cancer-onapristone XR]

    Source:
    SABCS 2021
    Test:

    nCounter® Breast Cancer 360™ Panel

    Title:
    Primary results of ONAWA (SOLTI-1802) trial: A window of opportunity trial of onapristone in postmenopausal women with progesterone receptor-positive/HER2-negative early breast cancer (EBC)
    Published date:
    10/09/2021
    Excerpt:
    Onapristone (ONA)...ONA XR significantly increases suppression of tumor cell proliferation in PgR-high primary breast cancer.
    Trial ID:
    ONAWA